Target intelligence / Profile preview

Enteric nervous system and vagus nerve pathway (ENS-VN pathway)

Target
ENS-VN pathway
Molecular classification
Other
01

Overview

The enteric nervous system (ENS) and vagus nerve pathway constitute the fundamental neural architecture of the gut-brain axis, enabling continuous bidirectional communication between the gastrointestinal tract and the brain (Furness, 2012). The ENS, often referred to as the "second brain," consists of millions of neurons organized into the myenteric and submucosal plexuses that autonomously regulate digestion, while the vagus nerve serves as the primary conduit for visceral sensory (afferent) and parasympathetic motor (efferent) signals (Breit et al., 2018). This pathway is critical for physiological processes such as nutrient sensing, gastric emptying, and the regulation of systemic inflammation through the cholinergic anti-inflammatory reflex (Pavlov & Tracey, 2012). Pathological changes in this circuit are linked to a wide range of disorders, including irritable bowel syndrome (IBS), gastroparesis, and obesity, as well as the early stages of Parkinson's disease, where alpha-synuclein pathology may travel from the gut to the brain via the vagus nerve (Braak et al., 2003). Therapeutic strategies include the use of GLP-1 receptor agonists to stimulate vagal satiety signals and 5-HT4 receptor agonists to enhance enteric neurotransmission, alongside non-pharmacological approaches like vagus nerve stimulation (VNS) for treating epilepsy and depression (Krieger, 2020).

Other names
Gut-brain axisVagal afferent pathwayEnteric-vagal circuitMicrobiota-gut-brain axisVagal-enteric signaling
02

Mechanism of action

Modulation of neural signaling through the activation or inhibition of specific receptors (e.g., 5-HT4, GLP-1R) on enteric neurons or vagal afferent fibers to alter gastrointestinal function and central feedback (Krieger, 2020; Furness, 2012).

03

Biological functions

Gastrointestinal motilitySatiety signalingImmune regulationNeuroendocrine signalingHomeostasisVisceral sensation
04

Disease associations

Irritable bowel syndromeInflammatory bowel diseaseObesityGastroparesisParkinson's diseaseDepressionAnxiety
05

Safety considerations

Autonomic side effectsNauseaVomitingBradycardiaSurgical complications from neuromodulation
06

Interacting drugs

4 more in the full profile.

07

Biomarkers

Heart rate variabilityGastric emptying timePlasma GLP-1 levelsFecal calprotectin

Beyond the preview

Go deeper on Enteric nervous system and vagus nerve pathway (ENS-VN pathway).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enteric nervous system and vagus nerve pathway (ENS-VN pathway).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call